ABOUT US
OUR STORY
Founded in July 2020, GenAssist Ltd. (GenAssist) is a pioneering gene editing drug company. The operation entity of GenAssist is located in Suzhou, China, with two subsidiaries in Shanghai (China) and Boston (US). GenAssist owns the global rights of Targeted AID-mediated Mutagenesis cytosine base editor technology. The company is dedicated to developing base editing drugs against life-threatening diseases.
Our Vision
To Benefit Human Health through Innovation
Our Mission
To Transform Cutting Edge Science Into Life-changing Medicine
LEADERSHIP
SCIENTIFIC ADVISORS
INVESTORS
